Supernus: New Approval Holds Promise Of Increased Growth
Supernus Pharmaceuticals' FDA approval for ONAPGO in Parkinson's Disease offers optimism despite past challenges, with a ...
FDA approves wearable infusion device for advanced Parkinson disease
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
Hosted on MSN17h
Supernus wins FDA approval for Parkinson’s pump on fourth try
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
MM&M14h
Rx Rundown: Sanofi, Bristol Myers Squibb, Omega Therapeutics and more
The agency approved Onapgo, a new Parkinson’s disease treatment from Supernus Pharmaceuticals. Cour Pharmaceuticals secured FDA Clearance of IND Application for CNP-103 in Type 1 Diabetes. The FDA ...